Tango Therapeutics, Inc. ($TNGX)
Filing Information
| Accession Number | 0001193125-26-207096 |
|---|---|
| Form Type | 4 |
| Filing Date | May 5, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
81,000
Total Value
$713,497.33
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President, R&D | Common Stock | โ | May 1, 2026 | Exercise/Conversion | 27,000 | $5.20 | $140,400.00 | 142,743 | Direct | โ | View Details | |
President, R&D | Common Stock | โ | May 1, 2026 | Sale | 25,900 | $21.19 | $548,901.29 | 116,843 | Direct | โ | View Details | |
President, R&D | Common Stock | โ | May 1, 2026 | Sale | 1,100 | $22.00 | $24,196.04 | 115,743 | Direct | โ | View Details | |
President, R&D | Stock Option (Right to Buy) | Derivative | May 1, 2026 | Exercise/Conversion | 27,000 | $0.00 | $0.00 | 368,040 | Direct | โ | View Details |